Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01857713 · ClinicalTrials.gov registry record · NA
Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device
A NA study of Laryngopharyngeal Reflux, sponsored by Somna Therapeutics, L.L.C..
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 5
- Study locations
NCT01857713: Completed NA study of Laryngopharyngeal Reflux, sponsored by Somna Therapeutics, L.L.C..
NCT01857713 is a NA study of Laryngopharyngeal Reflux that has completed, run by Somna Therapeutics, L.L.C.. The registered enrollment target is 95 participants, roughly in line with the 92-participant average among 3 other Laryngopharyngeal Reflux trials with a reported enrollment target. The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01857713, a NA study of Laryngopharyngeal Reflux, has completed, sponsored by Somna Therapeutics, L.L.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of the study is to determine the safety and effectiveness of non-invasive Reza Band UES Assist Device for the treatment of esophagopharyngeal reflux with extra-esophageal symptoms (chronic cough, choking, aspiration, chronic post nasal drip, globus, sore throat, throat clearing).
Primary Outcome
The RSI is a validated nine-item patient-administered outcome questionnaire designed to document symptoms and severity. Patients are asked to rate how nine problems have affected them on a scale of 0 (no problem) to 5 (severe problem), with a maximum total score of 45).
Conditions Studied
Interventions
- DEVICE Reza Band UES Assist Device
Study Locations (5)
New York
- Dr. Alan Raymond - New York
- Madison ENT & Facial Plastic surgery - New York
Wisconsin
- Wisconsin Center for Advanced Research - Milwaukee
- Aurora Health Care - Summit
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01857713 record still lists
NCT01857713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, roughly in line with the 92-participant average among 3 other Laryngopharyngeal Reflux trials with a reported enrollment target.
The record links to 1 condition, with Laryngopharyngeal Reflux appearing as the primary indexed condition, and to 1 intervention - of which Reza Band UES Assist Device is the first listed.
NCT01857713 lists 5 locations in 3 states (New York, Wisconsin, Tennessee).
Frequently Asked Questions
What is clinical trial NCT01857713 about?
NCT01857713 is a clinical study titled "Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device". The purpose of the study is to determine the safety and effectiveness of non-invasive Reza Band UES Assist Device for the treatment of esophagopharyngeal reflux with extra-esophageal symptoms (chronic cough, choking, aspiration, chronic post nasal drip, globus, sore throat, throat clearing).
What is the current status of trial NCT01857713?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2013-04. Estimated completion is 2013-09.
What conditions does trial NCT01857713 study?
This clinical trial studies the following conditions: Laryngopharyngeal Reflux.
What interventions are being tested in trial NCT01857713?
The interventions under investigation include: Reza Band UES Assist Device (DEVICE).
Who is sponsoring clinical trial NCT01857713?
This trial is sponsored by Somna Therapeutics, L.L.C., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01857713 being conducted?
This trial has 5 study locations across New York, Tennessee, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Laryngopharyngeal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia